| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |